BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33175078)

  • 1. Screening program for latent tuberculosis infection in asylum seekers - a single center experience in Pavia, Italy.
    Grecchi C; Sarda C; Manciulli T; Scudeller L; Leoni C; Mariani B; Cambieri P; Chinellato FE; Aquino IMG; Marone P; Ancarani C; Astroni L; Muzzi A; Brunetti E; Novati S
    Ann Ig; 2020; 32(6):682-688. PubMed ID: 33175078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Tuberculosis Infection Cascade of Care among Asylum Seekers in Verona, Italy.
    Bordin P; Gazzani D; Postiglione C; Conti E; Colucci L; Napoletano G; Bosco O; Moretti F; Majori S
    J Health Care Poor Underserved; 2022; 33(2):934-949. PubMed ID: 35574886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton.
    Sarivalasis A; Bodenmann P; Langenskiold E; Lutchmaya-Flick C; Daher O; Zellweger JP
    Swiss Med Wkly; 2013; 143():w13860. PubMed ID: 24018940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.
    Pontarelli A; Marchese V; Scolari C; Capone S; El-Hamad I; Donato F; Moioli R; Girardi E; Cirillo DM; Castelli F; Matteelli A
    Travel Med Infect Dis; 2019; 27():39-45. PubMed ID: 30347248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway.
    Harstad I; Heldal E; Steinshamn SL; Garåsen H; Winje BA; Jacobsen GW
    Scand J Public Health; 2010 May; 38(3):275-82. PubMed ID: 19914972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of latent tuberculosis treatment completion in immigrants seeking asylum in Sweden.
    Olsson O; Winqvist N; Olsson M; Olsson P; Björkman P
    Infect Dis (Lond); 2018 Sep; 50(9):678-686. PubMed ID: 29620426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.
    Mueller-Hermelink M; Kobbe R; Methling B; Rau C; Schulze-Sturm U; Auer I; Ahrens F; Brinkmann F
    Euro Surveill; 2018 Mar; 23(12):. PubMed ID: 29589578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study.
    Harstad I; Heldal E; Steinshamn SL; Garåsen H; Jacobsen GW
    BMC Public Health; 2009 May; 9():141. PubMed ID: 19442260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
    Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go UY; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M
    Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015.
    Buonfrate D; Gobbi F; Marchese V; Postiglione C; Badona Monteiro G; Giorli G; Napoletano G; Bisoffi Z
    Euro Surveill; 2018 Apr; 23(16):. PubMed ID: 29692316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.
    Spruijt I; Tesfay Haile D; Suurmond J; van den Hof S; Koenders M; Kouw P; van Noort N; Toumanian S; Cobelens F; Goosen S; Erkens C
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31537698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculin skin test versus interferon-gamma release assay in refugee children: A retrospective cohort study.
    Elliot C; Marais B; Williams P; Joshua P; Towle S; Hart G; Zwi K
    J Paediatr Child Health; 2018 Aug; 54(8):834-839. PubMed ID: 29442397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single and dual latent tuberculosis screening strategies before biologic and targeted therapy in patients with rheumatic diseases: a retrospective cohort study.
    Tang I; So H; Luk L; Wong V; Pang S; Lao V; Yip R
    Hong Kong Med J; 2020 Apr; 26(2):111-119. PubMed ID: 32245912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential strategy for the LTBI screening of newly-arrived immigrants in vulnerable social situations.
    Serre-Delcor N; Treviño-Maruri B; Tórtola MT; Fernández-Quevedo M; Soriano-Arandes A; Oliveira-Souto I; Espasa M; Molina I; Ascaso C
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):550-554. PubMed ID: 29223317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis.
    Banfield S; Pascoe E; Thambiran A; Siafarikas A; Burgner D
    PLoS One; 2012; 7(6):e38556. PubMed ID: 22701664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory.
    Trauer JM; Krause VL
    Med J Aust; 2011 Jun; 194(11):579-82. PubMed ID: 21644870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.